Last update 21 Dec 2024
Adalimumab biosimilar(Jiangsu Chia-tai Tianqing Pharmaceutical Co. Ltd.)
Last update 21 Dec 2024
Overview
Basic Info
Drug Type Biosimilar, Monoclonal antibody |
Synonyms 泰博维 |
Target |
Mechanism TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (18 Jan 2022), |
Regulation- |
Login to view timeline
Gene Sequence
Sequence Code 26792L
The sequence is quoted from: *****
Sequence Code 88699H
The sequence is quoted from: *****
Related
2
Clinical Trials associated with Adalimumab biosimilar(Jiangsu Chia-tai Tianqing Pharmaceutical Co. Ltd.)比较TQ-Z2301和修美乐@治疗活动性强直性脊柱炎的安全性及有效性多中心、随机、双盲、平行对照的临床研究
[Translation] A multicenter, randomized, double-blind, parallel-controlled clinical study comparing the safety and efficacy of TQ-Z2301 and Humira@ in the treatment of active ankylosing spondylitis
比较阿达木单抗注射液与修美乐在健康男性志愿者中药代动力学和安全性相似性的I期临床研究
[Translation] Phase I clinical study comparing the pharmacokinetics and safety of adalimumab injection and Humira in healthy male volunteers
100 Clinical Results associated with Adalimumab biosimilar(Jiangsu Chia-tai Tianqing Pharmaceutical Co. Ltd.)
Login to view more data
100 Translational Medicine associated with Adalimumab biosimilar(Jiangsu Chia-tai Tianqing Pharmaceutical Co. Ltd.)
Login to view more data
100 Patents (Medical) associated with Adalimumab biosimilar(Jiangsu Chia-tai Tianqing Pharmaceutical Co. Ltd.)
Login to view more data
100 Deals associated with Adalimumab biosimilar(Jiangsu Chia-tai Tianqing Pharmaceutical Co. Ltd.)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Rheumatoid Arthritis | CN | 18 Jan 2022 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Ankylosing Spondylitis | Phase 1 | CN | 17 Oct 2017 | |
| Arthritis, Psoriatic | Phase 1 | CN | 17 Oct 2017 | |
| Colitis, Ulcerative | Phase 1 | CN | 17 Oct 2017 | |
| Crohn Disease | Phase 1 | CN | 17 Oct 2017 | |
| Juvenile Idiopathic Arthritis | Phase 1 | CN | 17 Oct 2017 | |
| Plaque psoriasis | Phase 1 | CN | 17 Oct 2017 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free